Common Drug Review (CDR) Submission Deadlines and CDEC Meeting Dates

In the past, as CADTH does not have submission deadlines and submissions are reviewed on an ongoing basis, manufacturers could determine the tentative date when their submission would be considered based on the date the drug submission was received, the date it was deemed complete and other factors. However due to the recent queuing of submissions, CADTH has altered the way that targeted meeting dates are assigned.

Targeted meeting dates are now determined considering the date that the submission or resubmission is accepted for review by CADTH. CADTH still accepts applications for submissions and resubmissions for review through the CDR process at any time, therefore manufacturers are encouraged to file as soon as possible. All submissions and resubmissions will be assigned to the CDR work schedule for initiation of the review on a first-come, first-served basis as determined by the date the submission or resubmission is accepted for review by CADTH. Exceptions include submissions and resubmissions granted priority review status, requests for advice, and drug plan-initiated submissions or resubmissions.

Review Initiated By: Targeted CDEC Meeting Date:
February 17, 2017 June 21, 2017
March 17, 2017 July 19, 2017
May 18, 2017 September 20, 2017
June 15, 2017 October 18, 2017
July 14, 2017 November 15, 2017
August 23, 2017 December 13, 2017
September 11, 2017 January 17, 2018
October 16, 2017 February 21, 2018
November 13, 2017 March 21, 2018
December 08, 2017 April 18, 2018
January 15, 2018 May 16, 2018
February 16, 2018 June 20, 2018
March 16, 2018 July 18, 2018
May 17, 2018 September 19, 2018
June 14, 2018 October 17, 2018
July 20, 2018 November 21, 2018

*CADTH may add an August and/or December CDEC meeting when workload necessitates.